Clinical Trials Browser

Phase 2 × INDUSTRY × rovalpituzumab tesirine × Clear all

NCT02674568 2021-07-30

TRINITY

Phase 2 Completed

342 enrolled 18 charts

Recurrence, Small Cell Lung Carcinoma

NCT03543358 2021-01-05

A Long-Term Study of Rovalpituzumab Tesirine

Phase 2 Completed

3 enrolled 6 charts

Neoplasms